# A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine

> **NCT06995729** · PHASE1 · RECRUITING · sponsor: **Pfizer** · enrollment: 16 (estimated)

## Conditions studied

- Acute Treatment of Migraine

## Interventions

- **DRUG:** Zavegepant

## Key facts

- **NCT ID:** NCT06995729
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-16
- **Primary completion:** 2027-08-12
- **Final completion:** 2027-08-12
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2026-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06995729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06995729, "A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06995729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*